The MSD platform is ideal for immunogenicity testing or for multiplex biomarker and cytokine assays. The electrochemiluminescence technology enables high sensitivty levels combined with broad assay range. Ready to use off-the-shelf kits are available for various biomarkers, making it the perfect instrument for biomarker screening.

Platform intrinsic advantagesOur services at a glance
  • Highly sensitive assays
  • Fast and automated platform
  • Wide range of assay kits
  • In-house antibody pair testing
  • Assay development services
  • Multiplex biomarker assays
  • PK assays
  • Assay transfer
  • Assay validation (fit-for-purpose, non-reg., GLP confirm validation)
  • Regulated bioanalysis (non-reg / GCP / GLP)

Take advantage of Chimera Biotec‘s more than 20 years of in-depth experience as a specialty CRO for immunoassays which go beyond the scope of what is usually considered feasible.